APA (7th ed.) Citation

C, K., T, K., S, H., T, T., M, H., Y, M., . . . S, T. (2026). Acute Myeloid Leukemia with an FMS-like Tyrosine Kinase 3-tyrosine Kinase Domain Mutation Developing Gilteritinib-induced Differentiation Syndrome. Internal medicine (Tokyo, Japan), 65(5), 703. https://doi.org/10.2169/internalmedicine.5656-25

Chicago Style (17th ed.) Citation

C, Kubara, Kuriyama T, Hirakawa S, Tochigi T, Hayashi M, Matsuo Y, Eto T, and Taniguchi S. "Acute Myeloid Leukemia with an FMS-like Tyrosine Kinase 3-tyrosine Kinase Domain Mutation Developing Gilteritinib-induced Differentiation Syndrome." Internal Medicine (Tokyo, Japan) 65, no. 5 (2026): 703. https://doi.org/10.2169/internalmedicine.5656-25.

MLA (9th ed.) Citation

C, Kubara, et al. "Acute Myeloid Leukemia with an FMS-like Tyrosine Kinase 3-tyrosine Kinase Domain Mutation Developing Gilteritinib-induced Differentiation Syndrome." Internal Medicine (Tokyo, Japan), vol. 65, no. 5, 2026, p. 703, https://doi.org/10.2169/internalmedicine.5656-25.